Bausch Health Companies Inc.

GPTKB entity

Predicate	Object
gptkbp:instanceOf	gptkb:Company
gptkbp:acquisition	gptkb:Bausch_+_Lomb gptkb:Amoun_Pharmaceutical_Company gptkb:Ortho_Dermatologics gptkb:Solta_Medical
gptkbp:CEO	gptkb:Joseph_C._Papa
gptkbp:employees	21,000
gptkbp:focus	Gastroenterology Neurology Dermatology Eye health
gptkbp:founded	2013
gptkbp:headquarters	gptkb:Laval,_Quebec,_Canada
https://www.w3.org/2000/01/rdf-schema#label	Bausch Health Companies Inc.
gptkbp:industry	Pharmaceuticals
gptkbp:market	$8.5 billion (2021)
gptkbp:partnerships	gptkb:Eagle_Pharmaceuticals gptkb:Aerie_Pharmaceuticals gptkb:Santen_Pharmaceutical gptkb:Hikma_Pharmaceuticals Novartis
gptkbp:previouslyKnownAs	gptkb:Valeant_Pharmaceuticals_International,_Inc.
gptkbp:products	gptkb:Bausch_+_Lomb_Ultra_for_Myopia gptkb:Bausch_+_Lomb_Ultra_for_Astigmatism gptkb:Soolantra gptkb:Vigamox gptkb:Bausch_+_Lomb_Lacelle gptkb:Prolensa gptkb:Bausch_+_Lomb_PureVision gptkb:Bausch_+_Lomb_SofLens gptkb:Bausch_+_Lomb_Ultra_for_Presbyopia gptkb:Bausch_+_Lomb_Renu gptkb:Bausch_+_Lomb_Biotrue gptkb:Bepreve gptkb:Bausch_+_Lomb_ULTRA gptkb:Bausch_+_Lomb_Boston gptkb:Bausch_+_Lomb_Opti-Free gptkb:Lumify gptkb:Bausch_+_Lomb_BioTrue Xifaxan Durezol Lotemax Vyzulta Aqualox Bausch + Lomb BioTrue ONEday Retisert Zylet
gptkbp:revenue	$8.1 billion (2020)
gptkbp:stockExchange	gptkb:NYSE
gptkbp:stockSymbol	BHC
gptkbp:subsidiary	gptkb:Bausch_+_Lomb
gptkbp:tradedOn	gptkb:NYSE
gptkbp:website	www.bauschhealth.com